These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35070649)

  • 1. Optimal control and comprehensive cost-effectiveness analysis for COVID-19.
    Asamoah JKK; Okyere E; Abidemi A; Moore SE; Sun GQ; Jin Z; Acheampong E; Gordon JF
    Results Phys; 2022 Feb; 33():105177. PubMed ID: 35070649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal control and cost-effectiveness analysis for leptospirosis epidemic.
    Engida HA; Theuri DM; Gathungu DK; Gachohi J
    J Biol Dyn; 2023 Dec; 17(1):2248178. PubMed ID: 37695860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal control and cost-effectiveness analysis for the human melioidosis model.
    Engida HA; Gathungu DK; Ferede MM; Belay MA; Kawe PC; Mataru B
    Heliyon; 2024 Feb; 10(4):e26487. PubMed ID: 38434022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global stability and cost-effectiveness analysis of COVID-19 considering the impact of the environment: using data from Ghana.
    Asamoah JKK; Owusu MA; Jin Z; Oduro FT; Abidemi A; Gyasi EO
    Chaos Solitons Fractals; 2020 Nov; 140():110103. PubMed ID: 32834629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An optimal control model with cost effectiveness analysis of Maize streak virus disease in maize plant.
    Alemneh HT; Kassa AS; Godana AA
    Infect Dis Model; 2021; 6():169-182. PubMed ID: 33474519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of optimal control strategies on the HBV and COVID-19 co-epidemic spreading dynamics.
    Teklu SW
    Sci Rep; 2024 Mar; 14(1):5328. PubMed ID: 38438440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical modeling and optimal intervention strategies of the COVID-19 outbreak.
    Mondal J; Khajanchi S
    Nonlinear Dyn; 2022; 109(1):177-202. PubMed ID: 35125654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the impact of non-pharmaceutical interventions on the dynamics of novel coronavirus with optimal control analysis with a case study.
    Ullah S; Khan MA
    Chaos Solitons Fractals; 2020 Oct; 139():110075. PubMed ID: 32834618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Spread in Saudi Arabia: Modeling, Simulation and Analysis.
    Alrasheed H; Althnian A; Kurdi H; Al-Mgren H; Alharbi S
    Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33113936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity assessment and optimal economic evaluation of a new COVID-19 compartmental epidemic model with control interventions.
    Asamoah JKK; Jin Z; Sun GQ; Seidu B; Yankson E; Abidemi A; Oduro FT; Moore SE; Okyere E
    Chaos Solitons Fractals; 2021 May; 146():110885. PubMed ID: 33776250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the effects of preventive measures and vaccination on the COVID-19 spread in Benin Republic with optimal control.
    Agossou O; Atchadé MN; Djibril AM
    Results Phys; 2021 Dec; 31():104969. PubMed ID: 34804781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifurcation and optimal control analysis of HIV/AIDS and COVID-19 co-infection model with numerical simulation.
    Kotola BS; Teklu SW; Abebaw YF
    PLoS One; 2023; 18(5):e0284759. PubMed ID: 37146033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-region discrete time mathematical modeling of the dynamics of Covid-19 virus propagation using optimal control.
    Khajji B; Kada D; Balatif O; Rachik M
    J Appl Math Comput; 2020; 64(1-2):255-281. PubMed ID: 32390786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of infectious density-induced additional screening and treatment saturation on COVID-19: Modeling and cost-effective optimal control.
    Lamba S; Das T; Srivastava PK
    Infect Dis Model; 2024 Jun; 9(2):569-600. PubMed ID: 38558959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal control and cost effectiveness analysis for Newcastle disease eco-epidemiological model in Tanzania.
    Hugo A; Makinde OD; Kumar S; Chibwana FF
    J Biol Dyn; 2017 Dec; 11(1):190-209. PubMed ID: 27874314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of optimal control strategies on the fungal Tinea capitis infection fractional order model with cost-effective analysis.
    Teklu SW; Meshesha AA; Ullah S
    Sci Rep; 2024 Jan; 14(1):1508. PubMed ID: 38233520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional optimal control problem for an age-structured model of COVID-19 transmission.
    Khajji B; Kouidere A; Elhia M; Balatif O; Rachik M
    Chaos Solitons Fractals; 2021 Feb; 143():110625. PubMed ID: 33519119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal control for COVID-19 pandemic with quarantine and antiviral therapy.
    Masud MAB; Ahmed M; Rahman MH
    Sens Int; 2021; 2():100131. PubMed ID: 34766063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling and optimal control of pneumonia disease with cost-effective strategies.
    Tilahun GT; Makinde OD; Malonza D
    J Biol Dyn; 2017 Aug; 11(sup2):400-426. PubMed ID: 28613986
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.